Literature DB >> 17332491

Physiological roles of vascular nucleoside transporters.

Michaela Löffler1, Julio C Morote-Garcia, Shelley A Eltzschig, Imogen R Coe, Holger K Eltzschig.   

Abstract

Nucleoside transporters (NTs) comprise 2 widely expressed families, the equilibrative nucleoside transporters (diffusion-limited channels) and concentrative nucleoside transporters (sodium-dependent transporters). Because of their anatomic position at the blood-tissue interface, vascular NTs are in an ideal position to influence vascular nucleoside levels, particularly adenosine, which among others plays an important role in tissue protection during acute injury. For example, endothelial NTs contribute to preserving the vascular integrity during conditions of limited oxygen availability (hypoxia). Indeed, hypoxia-inducible factor-1-dependent repression of NTs results in enhanced extracellular adenosine signaling and thus attenuates hypoxia-associated increases in vascular leakage. In addition, vascular NTs also contribute to cardiac ischemic preconditioning, coronary vasodilation, and inhibition of platelet aggregation. Moreover, vascular nucleoside uptake via NTs is important for nucleoside recovery, particularly in cells lacking de novo nucleotide synthesis pathways (erythrocytes, leukocytes). Taken together, vascular NTs are critical in modulating adenosine-mediated responses during conditions such as inflammation or hypoxia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332491     DOI: 10.1161/ATVBAHA.106.126714

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  65 in total

Review 1.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

Review 2.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

3.  Adenosine kinase inhibition enhances microvascular dilator function and improves left ventricle diastolic dysfunction.

Authors:  Alec Davila; Yanna Tian; Istvan Czikora; Amanda S Weissman; Nicholas Weinand; Guangkuo Dong; Jiean Xu; Jie Li; Huabo Su; Gaston Kapuku; Yuqing Huo; Zsolt Bagi
Journal:  Microcirculation       Date:  2020-05-25       Impact factor: 2.628

Review 4.  What is the efficiency of ATP signaling from erythrocytes to regulate distribution of O(2) supply within the microvasculature?

Authors:  Christopher G Ellis; Stephanie Milkovich; Daniel Goldman
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

Review 5.  Perioperative organ injury.

Authors:  Karsten Bartels; Jörn Karhausen; Eric T Clambey; Almut Grenz; Holger K Eltzschig
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

6.  Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling.

Authors:  Qing Lu; Julie Newton; Vivian Hsiao; Paul Shamirian; Michael R Blackburn; Mesias Pedroza
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-28       Impact factor: 6.914

7.  Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.

Authors:  Melanie L Hart; Almut Grenz; Iris C Gorzolla; Jens Schittenhelm; Julee H Dalton; Holger K Eltzschig
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

Review 8.  The hypoxia-inflammation link and potential drug targets.

Authors:  Michael Koeppen; Tobias Eckle; Holger K Eltzschig
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

9.  Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.

Authors:  Holger K Eltzschig; David Köhler; Tobias Eckle; Tianqing Kong; Simon C Robson; Sean P Colgan
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.